| # | Drug | Count |
|---|---|---|
| 0 | LEVETIRACETAM | 40 |
| 1 | LEVETIRACETAM IN SODIUM CHLORIDE | 27 |
| 2 | LEVETIRACETAM INJECTION | 27 |
| 3 | LEVETIRACETAM ORAL | 27 |
| 4 | LACOSAMIDE | 24 |
| 5 | CARBAMAZEPINE | 22 |
| 6 | LAMOTRIGINE | 20 |
| 7 | METHOTREXATE SODIUM | 18 |
| 8 | CYTARABINE | 16 |
| 9 | METHOTREXATE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEBENDAZOLE | 1 | 0.0013 |
| 1 | OXCARBAZEPINE | 13 | 0.0008 |
| 2 | FOSPHENYTOIN SODIUM | 2 | 0.0008 |
| 3 | LACOSAMIDE | 24 | 0.0006 |
| 4 | PHENYTOIN | 13 | 0.0006 |
| 5 | CLOBAZAM | 9 | 0.0005 |
| 6 | FOSCARNET SODIUM | 2 | 0.0005 |
| 7 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 8 | MERCAPTOPURINE | 8 | 0.0005 |
| 9 | TEMOZOLOMIDE | 9 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anti-epileptic Agent [EPC] | 44 |
| 1 | Mood Stabilizer [EPC] | 34 |
| 2 | Corticosteroid [EPC] | 24 |
| 3 | Alkylating Drug [EPC] | 22 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 16 |
| 6 | Benzodiazepine [EPC] | 15 |
| 7 | Serotonin Reuptake Inhibitor [EPC] | 10 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 5 |
| 9 | Platinum-based Drug [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 2 | 0.0003 |
| 2 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 3 | Anti-epileptic Agent [EPC] | 44 | 0.0002 |
| 4 | Mood Stabilizer [EPC] | 34 | 0.0002 |
| 5 | Serotonin Reuptake Inhibitor [EPC] | 10 | 0.0001 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 7 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 9 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |